Substance Use Disorders: Primer On
Editat de Gerard Moeller, Mishka Terplanen Limba Engleză Paperback – 8 dec 2020
Preț: 442.64 lei
Preț vechi: 552.12 lei
-20% Nou
Puncte Express: 664
Preț estimativ în valută:
84.72€ • 89.37$ • 70.60£
84.72€ • 89.37$ • 70.60£
Carte disponibilă
Livrare economică 02-07 decembrie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780190920197
ISBN-10: 019092019X
Pagini: 384
Dimensiuni: 251 x 175 x 23 mm
Greutate: 0.7 kg
Editura: Oxford University Press
Colecția OUP USA
Seria Primer On
Locul publicării:New York, United States
ISBN-10: 019092019X
Pagini: 384
Dimensiuni: 251 x 175 x 23 mm
Greutate: 0.7 kg
Editura: Oxford University Press
Colecția OUP USA
Seria Primer On
Locul publicării:New York, United States
Notă biografică
F. Gerard "Gerry" Moeller, MD, is Director of the C. Kenneth and Dianne Wright Center for Clinical and Translational Research, and Associate Vice President for Clinical Research at Virginia Commonwealth University. He is also Director of the Institute for Drug and Alcohol Studies and Division Chair for Addiction Psychiatry. Awarded the C. Kenneth and Dianne Wright Distinguished Chair in Addiction Science, his research focuses on translational research on addictions, with a goal of developing novel treatments that reduce drug use and overdose. He is board certified in Psychiatry and Addiction Medicine.Mishka Terplan, MD, MPH, is board certified in both obstetrics and gynecology and in addiction medicine. His primary clinical, research, and advocacy interests lie along the intersections of reproductive and behavioral health. He is Associate Medical Director at Friends Research Institute and adjunct faculty at the University of California, San Francisco where he is a Substance Use Warmlineclinician for the National Clinical Consultation Center. He is also the Addiction Medicine Specialist for Virginia Medicaid and a consultant for the National Center on Substance Abuse and Child Welfare. Dr. Terplan has active has published over 100 peer-reviewed articles with emphasis on health disparities, stigma, and access to treatment.